rhil-21 (PeproTech)
PeproTech is a verified supplier 
90
Structured Review
PeproTech
rhil-21
Rhil 21, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-+21/rhil+21/pmc11556684-94-39-42
Average 90 stars, based on 1 article reviews
Rhil 21, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-+21/rhil+21/pmc11556684-94-39-42
Average 90 stars, based on 1 article reviews
rhil-21 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Recombinant:Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants Article Snippet: Single CD19 + CD2 - CD4 - CD10 - CD14 - IgD - IgG + PvDBPII-TH2 + B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants. Article Snippet: Single CD19+CD2-CD4-CD10-CD14-IgD-IgG+PvDBPII-TH2+ B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Generation of primary feline chimeric antigen receptor T cells. Article Snippet: 1 X 105 enriched T cells/well were seeded in 100 μL of complete XVIVO-15 in 96-well round-bottom tissue culture plates (Thermo) with 10 ng/mL rfIL-2 (R&D Systems) alone or in combination with 100 ng/mL Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T Article Snippet: The agents used in this study included the following: Article Title: B cell receptor dependent enhancement of dengue virus infection Article Snippet: Both 7B9 and 2F3 cells were generated by transduction of IgM–CD27+ memory B cells with a retrovirus encoding human B cell lymphoma (BCL)-6 and BCL-xL and enhanced green fluorescent protein (GFP) and culture on CD40L-expressing L cell fibroblasts and Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T. Article Snippet: The agents used in this study included the following: Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery. Article Snippet: The cells were resuspended in RPMI-1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin-streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L-glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL−1 animal-free Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery Article Snippet: The cells were resuspended in RPMI‐1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin‐streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L‐glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL −1 FACS:Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants Article Snippet: Single CD19 + CD2 - CD4 - CD10 - CD14 - IgD - IgG + PvDBPII-TH2 + B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants. Article Snippet: Single CD19+CD2-CD4-CD10-CD14-IgD-IgG+PvDBPII-TH2+ B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Generation of primary feline chimeric antigen receptor T cells. Article Snippet: 1 X 105 enriched T cells/well were seeded in 100 μL of complete XVIVO-15 in 96-well round-bottom tissue culture plates (Thermo) with 10 ng/mL rfIL-2 (R&D Systems) alone or in combination with 100 ng/mL Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T Article Snippet: The agents used in this study included the following: Article Title: B cell receptor dependent enhancement of dengue virus infection Article Snippet: Both 7B9 and 2F3 cells were generated by transduction of IgM–CD27+ memory B cells with a retrovirus encoding human B cell lymphoma (BCL)-6 and BCL-xL and enhanced green fluorescent protein (GFP) and culture on CD40L-expressing L cell fibroblasts and Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T. Article Snippet: The agents used in this study included the following: Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery. Article Snippet: The cells were resuspended in RPMI-1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin-streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L-glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL−1 animal-free Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery Article Snippet: The cells were resuspended in RPMI‐1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin‐streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L‐glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL −1 Isolation:Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants Article Snippet: Single CD19 + CD2 - CD4 - CD10 - CD14 - IgD - IgG + PvDBPII-TH2 + B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants. Article Snippet: Single CD19+CD2-CD4-CD10-CD14-IgD-IgG+PvDBPII-TH2+ B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Generation of primary feline chimeric antigen receptor T cells. Article Snippet: 1 X 105 enriched T cells/well were seeded in 100 μL of complete XVIVO-15 in 96-well round-bottom tissue culture plates (Thermo) with 10 ng/mL rfIL-2 (R&D Systems) alone or in combination with 100 ng/mL Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T Article Snippet: The agents used in this study included the following: Article Title: B cell receptor dependent enhancement of dengue virus infection Article Snippet: Both 7B9 and 2F3 cells were generated by transduction of IgM–CD27+ memory B cells with a retrovirus encoding human B cell lymphoma (BCL)-6 and BCL-xL and enhanced green fluorescent protein (GFP) and culture on CD40L-expressing L cell fibroblasts and Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T. Article Snippet: The agents used in this study included the following: Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery. Article Snippet: The cells were resuspended in RPMI-1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin-streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L-glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL−1 animal-free Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery Article Snippet: The cells were resuspended in RPMI‐1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin‐streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L‐glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL −1 Transfection:Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants Article Snippet: Single CD19 + CD2 - CD4 - CD10 - CD14 - IgD - IgG + PvDBPII-TH2 + B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants. Article Snippet: Single CD19+CD2-CD4-CD10-CD14-IgD-IgG+PvDBPII-TH2+ B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Generation of primary feline chimeric antigen receptor T cells. Article Snippet: 1 X 105 enriched T cells/well were seeded in 100 μL of complete XVIVO-15 in 96-well round-bottom tissue culture plates (Thermo) with 10 ng/mL rfIL-2 (R&D Systems) alone or in combination with 100 ng/mL Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T Article Snippet: The agents used in this study included the following: Article Title: B cell receptor dependent enhancement of dengue virus infection Article Snippet: Both 7B9 and 2F3 cells were generated by transduction of IgM–CD27+ memory B cells with a retrovirus encoding human B cell lymphoma (BCL)-6 and BCL-xL and enhanced green fluorescent protein (GFP) and culture on CD40L-expressing L cell fibroblasts and Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T. Article Snippet: The agents used in this study included the following: Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery. Article Snippet: The cells were resuspended in RPMI-1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin-streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L-glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL−1 animal-free Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery Article Snippet: The cells were resuspended in RPMI‐1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin‐streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L‐glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL −1 Cytotoxicity Assay:Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants Article Snippet: Single CD19 + CD2 - CD4 - CD10 - CD14 - IgD - IgG + PvDBPII-TH2 + B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants. Article Snippet: Single CD19+CD2-CD4-CD10-CD14-IgD-IgG+PvDBPII-TH2+ B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Generation of primary feline chimeric antigen receptor T cells. Article Snippet: 1 X 105 enriched T cells/well were seeded in 100 μL of complete XVIVO-15 in 96-well round-bottom tissue culture plates (Thermo) with 10 ng/mL rfIL-2 (R&D Systems) alone or in combination with 100 ng/mL Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T Article Snippet: The agents used in this study included the following: Article Title: B cell receptor dependent enhancement of dengue virus infection Article Snippet: Both 7B9 and 2F3 cells were generated by transduction of IgM–CD27+ memory B cells with a retrovirus encoding human B cell lymphoma (BCL)-6 and BCL-xL and enhanced green fluorescent protein (GFP) and culture on CD40L-expressing L cell fibroblasts and Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T. Article Snippet: The agents used in this study included the following: Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery. Article Snippet: The cells were resuspended in RPMI-1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin-streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L-glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL−1 animal-free Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery Article Snippet: The cells were resuspended in RPMI‐1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin‐streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L‐glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL −1 Generated:Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants Article Snippet: Single CD19 + CD2 - CD4 - CD10 - CD14 - IgD - IgG + PvDBPII-TH2 + B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants. Article Snippet: Single CD19+CD2-CD4-CD10-CD14-IgD-IgG+PvDBPII-TH2+ B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Generation of primary feline chimeric antigen receptor T cells. Article Snippet: 1 X 105 enriched T cells/well were seeded in 100 μL of complete XVIVO-15 in 96-well round-bottom tissue culture plates (Thermo) with 10 ng/mL rfIL-2 (R&D Systems) alone or in combination with 100 ng/mL Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T Article Snippet: The agents used in this study included the following: Article Title: B cell receptor dependent enhancement of dengue virus infection Article Snippet: Both 7B9 and 2F3 cells were generated by transduction of IgM–CD27+ memory B cells with a retrovirus encoding human B cell lymphoma (BCL)-6 and BCL-xL and enhanced green fluorescent protein (GFP) and culture on CD40L-expressing L cell fibroblasts and Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T. Article Snippet: The agents used in this study included the following: Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery. Article Snippet: The cells were resuspended in RPMI-1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin-streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L-glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL−1 animal-free Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery Article Snippet: The cells were resuspended in RPMI‐1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin‐streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L‐glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL −1 Transduction:Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants Article Snippet: Single CD19 + CD2 - CD4 - CD10 - CD14 - IgD - IgG + PvDBPII-TH2 + B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Atypical memory B cells from natural malaria infection produced broadly neutralizing antibodies against Plasmodium vivax variants. Article Snippet: Single CD19+CD2-CD4-CD10-CD14-IgD-IgG+PvDBPII-TH2+ B cells were sorted onto pre-cultured MS40L-low feeder cells in 96 F plates containing RPMI 1640 medium supplemented with 10% FBS, 55 μM 2-mercaptoethanol (2-ME), penicillin (100 U/mL), streptomycin (100 μg/mL), 10 mM HEPES, 1 mM sodium pyruvate, 1% minimal essential medium non-essential amino acids, recombinant human interleukin-2 (IL-2; 50 ng/mL; PeproTech), Article Title: Generation of primary feline chimeric antigen receptor T cells. Article Snippet: 1 X 105 enriched T cells/well were seeded in 100 μL of complete XVIVO-15 in 96-well round-bottom tissue culture plates (Thermo) with 10 ng/mL rfIL-2 (R&D Systems) alone or in combination with 100 ng/mL Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T Article Snippet: The agents used in this study included the following: Article Title: B cell receptor dependent enhancement of dengue virus infection Article Snippet: Both 7B9 and 2F3 cells were generated by transduction of IgM–CD27+ memory B cells with a retrovirus encoding human B cell lymphoma (BCL)-6 and BCL-xL and enhanced green fluorescent protein (GFP) and culture on CD40L-expressing L cell fibroblasts and Article Title: Systemic tumor regression with synergy therapy: radiotherapy and CAR-T. Article Snippet: The agents used in this study included the following: Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery. Article Snippet: The cells were resuspended in RPMI-1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin-streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L-glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL−1 animal-free Article Title: Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery Article Snippet: The cells were resuspended in RPMI‐1640 medium (Corning, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, USA), 1% penicillin‐streptomycin (Gibco, Thermo Fisher Scientific, USA), 5 mM L‐glutamine (Gibco, Thermo Fisher Scientific), 10 IU mL −1 |